Table 1.

No.	Age	GS	Prior T	PSA	Ongoing T	FD	FECH-PET	BS	Interval
1	79	n/a	RP	3.01	NIL	LN-M	LN-M	Neg	4
2	64	7	RP + HIFU	6.5	NIL	LN-M	LN-M	Neg	14
3	75	n/a	RP + AHT	7.7	NIL	LN-M	LN-M	Neg	24
4	74	5	RTx	19	AHT	LN-M	LN-M	FP	0
5	60	3	RP	0.4	NIL	LN-M	LN-M	Neg	35
6	63	8	AHT	4.8	NIL	LR	LR	Neg	2
7	69	9	RP + AHT	1.9	NIL	LR	LR	Neg	11
8	76	n/a	RP	0.8	NIL	PM	PM	Neg	18
9	70	7	RP + RTx	3.6	NIL	NDR	Neg	Neg	38
10	59	9	RP + RTx	0.3	NIL	NDR	Neg	Neg	14
11	85	7	RTx	1.56	NIL	NDR	Neg	Neg	9
12	65	8	RP	0.66	NIL	NDR	Neg	Neg	3
13	73	n/a	RP	0.4	NIL	NDR	Neg	Neg	1
14	79	n/a	RP	0.4	NIL	NDR	Neg	Neg	1
15	68	n/a	RP + RTx	0.5	NIL	NDR	Neg	FP	25
16	68	7	RP + RTx	1.6	NIL	NDR	Neg	Neg	4
17	69	7	RP + RTx	1.9	NIL	NDR	Neg	Neg	3
18	68	9	RP + RTx	0.9	NIL	NDR	Neg	Neg	42
19	80	n/a	RTx	0.3	NIL	NDR	Neg	Neg	25
20	63	9	AHT	13.1	AHT	OSS	OSS	OSS	22
21	70	7	RP	1	NIL	OSS	OSS	OSS	45
22	71	7	RP + RTx	12.9	NIL	OSS	OSS	OSS	5
23	77	8	RP + RTx	1.8	RTx	OSS	OSS	OSS	24
24	69	8	RP + RTx	1.7	NIL	OSS	OSS	OSS	9
25	56	9	RP + RTx + AHT	6.7	Docetaxel	OSS	OSS	OSS	4
26	71	8	RTx	2.9	AHT	OSS	OSS	OSS	15
27	59	8	RTx	3.63	NIL	OSS	OSS	OSS	11
28	61	8	RP	1.9	AHT	OSS	OSS	OSS	6
29	73	9	RP	21	NIL	OSS + LN-M	OSS + LN-M	OSS	7
30	71	8	RTx	5	AHT	OSS + PM	OSS + PM	OSS	45
31	66	7	RP + RTx	21	Docetaxel	OSS + LN-M	LN-M FN	OSS	14
32	64	7	RP + AHT	1	AHT	OSS + LN-M	LN-M FN	OSS	7
33	76	7	RP	5.6	NIL	OSS	FN	OSS	3
34	67	7	RTx	4.5	NIL	OSS	OSS	FN	18
35	65	7	RP	12.1	NIL	OSS	OSS	OSS	2
36	62	9	AHT	14	AHT	OSS	OSS	OSS	11
37	77	n/a	RP + RTx	4	NIL	OSS	OSS	OSS	5

PR: radical prostatectomy, RTx: radiation therapy, CTx: chemotherapy, NIL: nothing, AHT: hormone/androgen deprivation therapy, LN-M: lymph node metastasis, OSS: bone metastasis, PM: pulmonary metastasis, Neg: negative finding.